Bay Harbor Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bay Harbor Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-41	Closed	-$6K	–	313
2020 Q4	$6K	Hold	41	–	–	﹤0.01%	268
2020 Q3	$6K	Buy	+41	New	+$5.56K	﹤0.01%	248
2020 Q2	–	Sell	-10	Closed	-$1K	–	375
2020 Q1	$1K	Buy	+10	New	+$1.15K	﹤0.01%	305
2019 Q2	–	Sell	-144	Closed	-$16K	–	377
2019 Q1	$16K	Buy	144 +25	+21%	+$2.74K	0.01%	246
2018 Q4	$11K	Buy	+119	New	+$12.6K	0.01%	248

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bay Harbor Wealth Management's IBB Position: Q1 2021 in Review

Bay Harbor Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q1 2021, closing a stake of 41 shares — an estimated $6K sold.

Bay Harbor Wealth Management first reported a position in IBB in Q4 2018 and held it in 5 quarters. The position peaked at $16K in Q1 2019. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

Bay Harbor Wealth Management reported no remaining iShares Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
Bay Harbor Wealth Management sold 41 iShares Biotechnology ETF shares in Q1 2021, an estimated $6K.
Bay Harbor Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 5 quarters.
Bay Harbor Wealth Management's iShares Biotechnology ETF position peaked at $16K in Q1 2019.
845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on Bay Harbor Wealth Management's 13F filing for Q1 2021, filed 5 May 2021.